Seeing Is Believing
SRPT is currently covered by 26 analysts with an average price target of $44.49. This is a potential upside of $26.23 (143.65%) from yesterday's end of day stock price of $18.26.
Sarepta Therapeutics's activity chart (see below) currently has 687 price targets and 672 ratings on display. The stock rating distribution of SRPT is 67.26% BUY, 22.02% HOLD and 10.71% SELL.
Analysts average stock forecasts to be materialized ratio is 56.2% with an average time for these price targets to be met of 269.29 days.
Highest price target for SRPT is $150, Lowest price target is $10, average price target is $65.48.
Most recent stock forecast was given by TAZEEN AHMAD from BAML on 21-Aug-2025. First documented stock forecast 20-Mar-2013.
Currently out of the existing stock ratings of SRPT, 113 are a BUY (67.26%), 37 are a HOLD (22.02%), 18 are a SELL (10.71%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$16
$-4.22 (-20.87%)
$10
5 days ago
(21-Aug-2025)
4/16 (25%)
$-4.06 (-20.24%)
246
Sell
$12
$-8.22 (-40.65%)
$9
11 days ago
(15-Aug-2025)
1/9 (11.11%)
$-9.81 (-44.98%)
27
Hold
$19
$-1.22 (-6.03%)
$29
19 days ago
(07-Aug-2025)
4/14 (28.57%)
$1.04 (5.79%)
100
Sell
$22
$1.78 (8.80%)
$10
27 days ago
(30-Jul-2025)
12/25 (48%)
$5.25 (31.34%)
558
Sell
28 days ago
(29-Jul-2025)
11/33 (33.33%)
$28.03 (127.58%)
349
What is SRPT (Sarepta Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on SRPT (Sarepta Therapeutics) with a proven track record?
Which analyst has the most public recommendations on SRPT (Sarepta Therapeutics)?
Which analyst is the currently most bullish on SRPT (Sarepta Therapeutics)?
Which analyst is the currently most reserved on SRPT (Sarepta Therapeutics)?